Skip to main content
Erschienen in: Virchows Archiv 5/2008

01.11.2008 | Original Article

Intratumoural lymphatics in benign and malignant soft tissue tumours

verfasst von: G. Mahendra, K. Kliskey, K. Williams, K. Hollowood, D. Jackson, N. A. Athanasou

Erschienen in: Virchows Archiv | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Soft tissue sarcomas do not generally metastasise via lymphatics, and the presence or absence of lymphatic vessels within sarcomas and benign soft tissue tumours is not known. In this study, we determined whether lymphatic vessels were present in a wide range of benign and malignant soft tissue lesions by examining intratumoural expression of the lymphatic endothelial cell markers, Lyve-1 and podoplanin. Intratumoural Lyve-1+/podoplanin+ lymphatics were not identified in sarcomas apart from all cases of epithelioid sarcoma (a tumour which is known to metastasise to lymph nodes) and a few cases of leiomyosarcoma, rhabdomyosarcoma and synovial sarcoma. Intratumoural lymphatics were also absent in most benign soft tissue tumours. Reparative and inflammatory soft tissue lesions contained lymphatics, as did all (pseudosarcomatous) proliferative myofibroblastic lesions including nodular, proliferative and ischaemic fasciitis, elastofibroma, nuchal fibroma and deep fibromatosis. Our results show that most soft tissue sarcomas do not contain intratumoural lymphatics, a finding which is consistent with the infrequent finding of sarcoma metastasis to lymph nodes. In contrast to fibrosarcoma and a number of other malignant spindle cell tumours, proliferative fibroblastic/myofibroblastic lesions of soft tissue contain intralesional lymphatic vessels.
Literatur
1.
Zurück zum Zitat Sondak VK, Chang AE (2001) Clinical evaluation and treatment of soft tissue tumours. In: Weiss SW, Goldblum JR (eds) Enzinger and Weiss’s soft tissue tumours. 4th edn. Mosby, St. Louis, pp 21–44 Sondak VK, Chang AE (2001) Clinical evaluation and treatment of soft tissue tumours. In: Weiss SW, Goldblum JR (eds) Enzinger and Weiss’s soft tissue tumours. 4th edn. Mosby, St. Louis, pp 21–44
2.
Zurück zum Zitat Fong Y, Coit DG, Woodruff JM et al (1993) Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 217:72–77PubMedCrossRef Fong Y, Coit DG, Woodruff JM et al (1993) Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 217:72–77PubMedCrossRef
3.
Zurück zum Zitat Behranwala KA, A’Hern R, Omar A et al (2004) Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol 11:714–719PubMedCrossRef Behranwala KA, A’Hern R, Omar A et al (2004) Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol 11:714–719PubMedCrossRef
4.
Zurück zum Zitat Weingrad DN, Rosenburg SA (1978) Early lymphatic spread of osteogenic and soft-tissue sarcomas. Surgery 84:231–240PubMed Weingrad DN, Rosenburg SA (1978) Early lymphatic spread of osteogenic and soft-tissue sarcomas. Surgery 84:231–240PubMed
5.
Zurück zum Zitat Williams CSM, Leek RD, Robson AM et al (2003) Absence of lymphangiogenesis and intratumoral lymph vessels in human metastatic breast cancer. J Pathol 200:195–206PubMedCrossRef Williams CSM, Leek RD, Robson AM et al (2003) Absence of lymphangiogenesis and intratumoral lymph vessels in human metastatic breast cancer. J Pathol 200:195–206PubMedCrossRef
6.
Zurück zum Zitat Bono P, Wasenius V, Heikkilä P et al (2004) High Lyve-1 positive lymphatic vessels are associated with poor outcome in breast cancer. Clin Cancer Res 10:7144–7149PubMedCrossRef Bono P, Wasenius V, Heikkilä P et al (2004) High Lyve-1 positive lymphatic vessels are associated with poor outcome in breast cancer. Clin Cancer Res 10:7144–7149PubMedCrossRef
7.
Zurück zum Zitat Hosking B, Makinen T (2007) Lymphatic vasculature: a molecular perspective. Bioessays 29:1192–1202PubMedCrossRef Hosking B, Makinen T (2007) Lymphatic vasculature: a molecular perspective. Bioessays 29:1192–1202PubMedCrossRef
8.
Zurück zum Zitat Ji RC (2005) Characteristics of lymphatic endothelial cells in physiological and pathological conditions. Histol Histopathol 20:155–175PubMed Ji RC (2005) Characteristics of lymphatic endothelial cells in physiological and pathological conditions. Histol Histopathol 20:155–175PubMed
9.
Zurück zum Zitat Schledzewski K, Falkowski M, Moldenhauer G et al (2006) Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implication for the assessment of lymphangiogenesis. J Pathol 209:67–77PubMedCrossRef Schledzewski K, Falkowski M, Moldenhauer G et al (2006) Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implication for the assessment of lymphangiogenesis. J Pathol 209:67–77PubMedCrossRef
10.
Zurück zum Zitat Montgomery EA, Meis JM (1991) Nodular fasciitis; its morphological spectrum and immunohistochemical profile. Am J Surg Pathol 15:942–948PubMedCrossRef Montgomery EA, Meis JM (1991) Nodular fasciitis; its morphological spectrum and immunohistochemical profile. Am J Surg Pathol 15:942–948PubMedCrossRef
11.
Zurück zum Zitat Soule EH, Minn R (1975) Proliferative (nodular) fasciitis. Arch Pathol 73:17–24 Soule EH, Minn R (1975) Proliferative (nodular) fasciitis. Arch Pathol 73:17–24
12.
Zurück zum Zitat Akerman M (1997) Benign fibrous lesions masquerading as sarcomas; clinical and morphological pitfalls. Acta Orthop Scand 68:37–40 Akerman M (1997) Benign fibrous lesions masquerading as sarcomas; clinical and morphological pitfalls. Acta Orthop Scand 68:37–40
13.
Zurück zum Zitat Kim ST, Kim HJ, Park SW et al (2005) Nodular fasciitis in the head and neck: CT and MR imaging findings. Am J Neuroradiol 26:2617–2623PubMed Kim ST, Kim HJ, Park SW et al (2005) Nodular fasciitis in the head and neck: CT and MR imaging findings. Am J Neuroradiol 26:2617–2623PubMed
14.
Zurück zum Zitat Pritchard DJ, Nascimento AG, Petersen IA (1996) Local control of extra-abdominal desmoid tumors. J Bone Joint Surg 78A:848–854 Pritchard DJ, Nascimento AG, Petersen IA (1996) Local control of extra-abdominal desmoid tumors. J Bone Joint Surg 78A:848–854
15.
Zurück zum Zitat Lopez R, Kemalyan N, Moseley HS et al (1990) Problems in diagnosis and management of desmoid tumors. Am J Surg 159:450–453PubMedCrossRef Lopez R, Kemalyan N, Moseley HS et al (1990) Problems in diagnosis and management of desmoid tumors. Am J Surg 159:450–453PubMedCrossRef
16.
Zurück zum Zitat De Wever I, Cin PD, Fletcher CDM et al (2000) Cytogenetics, clinical and morphological correlation in 78 cases of fibromatosis: a report from the CHAMP study group. Mod Pathol 13:1080–1085PubMedCrossRef De Wever I, Cin PD, Fletcher CDM et al (2000) Cytogenetics, clinical and morphological correlation in 78 cases of fibromatosis: a report from the CHAMP study group. Mod Pathol 13:1080–1085PubMedCrossRef
17.
Zurück zum Zitat Breiteneder-Geleff S, Soleiman A, Kowalski H et al (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385–394PubMed Breiteneder-Geleff S, Soleiman A, Kowalski H et al (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385–394PubMed
18.
Zurück zum Zitat Banerji S, Ni J, Wang S et al (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789–801PubMedCrossRef Banerji S, Ni J, Wang S et al (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789–801PubMedCrossRef
19.
Zurück zum Zitat Fletcher CDM, Unni KK, Mertens F (eds) (2002) World Health Organisation classification of tumours. pathology and genetics of tumours of soft tissue and bone. IARC, Lyon Fletcher CDM, Unni KK, Mertens F (eds) (2002) World Health Organisation classification of tumours. pathology and genetics of tumours of soft tissue and bone. IARC, Lyon
20.
Zurück zum Zitat Ordóñez NG (2005) D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 36:372–380PubMedCrossRef Ordóñez NG (2005) D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 36:372–380PubMedCrossRef
21.
Zurück zum Zitat De Visscher SAHJ, Ginkel RJV, Wobbes T et al (2006) Epithelioid sarcoma: still an only surgically curable disease. Cancer 107:606–612PubMedCrossRef De Visscher SAHJ, Ginkel RJV, Wobbes T et al (2006) Epithelioid sarcoma: still an only surgically curable disease. Cancer 107:606–612PubMedCrossRef
22.
Zurück zum Zitat Chase DR, Enzinger FM (1985) Epithelioid sarcoma: diagnosis, prognostic indicators and treatment. Am J Surg Pathol 9:241–263PubMedCrossRef Chase DR, Enzinger FM (1985) Epithelioid sarcoma: diagnosis, prognostic indicators and treatment. Am J Surg Pathol 9:241–263PubMedCrossRef
23.
Zurück zum Zitat Baratti D, Pennacchioli E, Casali PG et al (2007) Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol 12:3542–3551CrossRef Baratti D, Pennacchioli E, Casali PG et al (2007) Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol 12:3542–3551CrossRef
24.
Zurück zum Zitat Friedrichs N, Hahne JC, Pepper MS et al (2006) Immunohistochemical quantification of lymph vessels, VEGF-C and VEGF receptor 3 in human sarcomas. Histopathology 49:87–88PubMedCrossRef Friedrichs N, Hahne JC, Pepper MS et al (2006) Immunohistochemical quantification of lymph vessels, VEGF-C and VEGF receptor 3 in human sarcomas. Histopathology 49:87–88PubMedCrossRef
25.
Zurück zum Zitat Beasley NJ, Prevo R, Banerji S et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315–1320PubMed Beasley NJ, Prevo R, Banerji S et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315–1320PubMed
26.
Zurück zum Zitat Stacker SA, Baldwin ME, Achen MG et al (2002) The role of tumour lymphangiogenesis in metastatic spread. FASEB J 16:922–934PubMedCrossRef Stacker SA, Baldwin ME, Achen MG et al (2002) The role of tumour lymphangiogenesis in metastatic spread. FASEB J 16:922–934PubMedCrossRef
27.
Zurück zum Zitat Pepper MS, Skobe M (2003) Lymphatic endothelium: morphological, molecular and functional properties. J Cell Biol 163:209–213PubMedCrossRef Pepper MS, Skobe M (2003) Lymphatic endothelium: morphological, molecular and functional properties. J Cell Biol 163:209–213PubMedCrossRef
28.
Zurück zum Zitat Padera TM, Kadambi A, di Tomaso E et al (2002) Lymphatic metastasis in the absence of functional intratumoural lymphatics. Science 296:1883–1886PubMedCrossRef Padera TM, Kadambi A, di Tomaso E et al (2002) Lymphatic metastasis in the absence of functional intratumoural lymphatics. Science 296:1883–1886PubMedCrossRef
29.
Zurück zum Zitat Leu AJ, Berk DA, Lymboussaki A et al (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324–4327PubMed Leu AJ, Berk DA, Lymboussaki A et al (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324–4327PubMed
30.
Zurück zum Zitat Jain RK, Fenton BT (2002) Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J Natl Cancer Inst 94:417–421PubMed Jain RK, Fenton BT (2002) Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J Natl Cancer Inst 94:417–421PubMed
31.
Zurück zum Zitat Maula SM, Luukkaa M, Grénman R et al (2003) Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinoma of the head and neck region. Cancer Res 63:1920–1926PubMed Maula SM, Luukkaa M, Grénman R et al (2003) Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinoma of the head and neck region. Cancer Res 63:1920–1926PubMed
32.
Zurück zum Zitat Dadras SS, Paul T, Bertoncini J et al (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162:1951–1960PubMed Dadras SS, Paul T, Bertoncini J et al (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162:1951–1960PubMed
33.
Zurück zum Zitat Hall FT, Freeman JL, Jackson DG et al (2003) Intratumoral lymphatics and lymph node metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 129:716–719PubMedCrossRef Hall FT, Freeman JL, Jackson DG et al (2003) Intratumoral lymphatics and lymph node metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 129:716–719PubMedCrossRef
34.
Zurück zum Zitat Cursiefen C, Chen L, Borges LP et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040–1050PubMed Cursiefen C, Chen L, Borges LP et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040–1050PubMed
35.
Zurück zum Zitat Weiss SW, Goldblum JR (2001) Fibromatosis. In: Weiss SW, Goldblum JR (eds) Enzinger and Weiss’s soft tissue tumours. 4th edn. Mosby, St. Louis, pp 309–346 Weiss SW, Goldblum JR (2001) Fibromatosis. In: Weiss SW, Goldblum JR (eds) Enzinger and Weiss’s soft tissue tumours. 4th edn. Mosby, St. Louis, pp 309–346
36.
Zurück zum Zitat Weiss SW, Goldblum JR (2001) Benign fibrous tissue lesions. In: Weiss SW, Goldblum JR (eds) Enzinger and Weiss’s soft tissue tumours. 4th edn. Mosby, St. Louis, pp 247–307 Weiss SW, Goldblum JR (2001) Benign fibrous tissue lesions. In: Weiss SW, Goldblum JR (eds) Enzinger and Weiss’s soft tissue tumours. 4th edn. Mosby, St. Louis, pp 247–307
Metadaten
Titel
Intratumoural lymphatics in benign and malignant soft tissue tumours
verfasst von
G. Mahendra
K. Kliskey
K. Williams
K. Hollowood
D. Jackson
N. A. Athanasou
Publikationsdatum
01.11.2008
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 5/2008
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-008-0660-3

Weitere Artikel der Ausgabe 5/2008

Virchows Archiv 5/2008 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …